Edward Parsons

KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA.

NuVasive Clinical Services Monitoring, Inc. provides onsite and web-based monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. It facilitates the surgical process and reduces surgical risk by providing critical information and alerts to surgeons of potential harm or compromise to the spinal cord or neural structures. The company was founded by Roger Conley in 2000 and is headquartered in San Diego, CA.

Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.

Allegro Diagnostics Corp. develops and commercializes molecular diagnostics system. It focuses on lung cancer and other pulmonary diseases using proprietary gene expression technology originating within the Pulmonary Center at the Boston University School of Medicine. The company was founded by Jerome S. Brody and Avrum Spira on April 20, 2007 and is headquartered in Maynard, MA.

SafeOp Surgical, Inc. operates as a medical device company. It offers portable neuro monitoring devices that enable the detection of nerve damage, such as positioning effect, an injury to peripheral nerves related to patient positioning during surgery or prolonged sedation. The company was founded in 2011 and is headquartered in Hunt Valley, MD.

Ocudyne, Inc.provides vegetarian dietary supplement products. The company is headquartered in Roseville, MN.

Tullis Health Investor Inc (Tullis Health) is a private equity and venture capital firm founded in 1986 by Jim Tullis. The firm is headquartered in Palm Beach, Florida.

Johnson & Johnson Vision Care, Inc. manufactures and markets vision care products. The company was founded on March 07, 1962 and is headquartered in Jacksonville, FL.

Serum Institute of India Pvt Ltd. engages in the production and exportation of anti-cancer products and viral vaccines. Its products include bacterial vaccines, recombinant and combination vaccines, viral vaccines, influenza vaccines. uro-oncology, and polysaccharide conjugate vaccine. The company was founded by Cyrus S. Poonawalla in 1966 and is headquartered in Pune, India.

CEO Roundtable on Cancer, Inc. promotes activities to reduce cancer risk, enable early detection, facilitate better access to treatment and hasten the discovery. Its programs include CEO cancer gold standard, life sciences consortium and project data sphere. The company was founded by George H. W. Bush in 2001 and is headquartered in Durham, NC.

Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.

Tyrogenex, Inc. operates as a biopharmaceutical company which develops dual vascular endothelial growth factor receptor and platelet-derived growth factor receptor inhibitors for wet age-related macular degeneration and solid tumors. Its compound targets the basic mechanisms of neovascular eye diseases, including angiogenesis, fibrosis and inflammation. The company was founded by Chris Liang, Teri Ardleigh Swift, and Sheridan G. Snyder and is headquartered in Rockville, MD.

AXA Investment Managers (Paris) SA (Investment Management) (AXA IM) is the structured finance division of AXA Investment Managers (Paris) SA, itself a subsidiary of AXA SA (XP: CS) in France. Created in 2000, the firm is a dedicated buy-side platform which is organized into investment teams specializing in managing structured finance products including corporate credit, structured credit invest, asset backed securities and insurance linked securities for a range of clients including pension funds, corporations, governments, institutions and insurance companies. Their Responsible Investment team utilizes AXA Investment Managers' multi-expert model and RI Search© to conducts ESG research that informs investment decision-making and active stewardship practices.

Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA.

Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements.

TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA.

Deuterx LLC engages in research of biotechnology. It also engages in development of biotechnology. The company was founded by Anthony W. Czarnik in 2012 and is headquartered in Andover, MA.

IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV.

Ophirex, Inc. develops antidotes to snakebite. The company was founded by Jerry D. Harrison and Matthew Lewin and is headquartered in Corte Madera, CA.

Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York.

Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation.

Maternal Newborn Health Innovations Corp. is a company based in Kinnelon, NJ. Gary M. Cohen has been the CEOs since incorporation. Maternal Newborn Health Innovations Corp. was founded by Gary M. Cohen.